Asymmetric dimethylarginine (ADMA) as a novel independent risk factor for cardiovascular disease in haemodialysis patients

Abstrakt

Asymmetric dimethylarginine is independent of all other measured cardiovascular risk factors including homocysteine in hemodialysis patients.